Bone marrow failure research program (BMFRP) services in support of congressionally directed medical research programs (CDMRP)
Ended Awarded Last action
- Contract number
- W81XWH20F0134
- Awardee
-
Leidos, Inc. UEI QLNMVC12KWY3 Part of Leidos Holdings, Inc.
- Awarding agency
-
Defense Health Agency
Department of Defense
- Obligated
- $328,176
Award facts
- Opportunity
-
- W81XWH17R0036 Solicitation number
- Meeting, Scientific and Administrative Support Services (MSASS), Request for Proposal (RFP) Award Notice · Posted Apr 12, 2017
- Meeting, Scientific and Administrative Support Services Award Notice · Posted Mar 22, 2017
- Contract value 87% obligated
-
- $328,175.59 Current, with exercised options
- $376,777.73 Potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Funding agency
- Medical Command Department of the Army, Department of Defense
- NAICS code
- 541690 Other Scientific and Technical Consulting Services
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Two Step
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Frederick, MD 21702, USA
- Legislative mandates
-
- Service Contract Act FAR subpart 22.10
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | -$3,874 | |
| Funding Only Action | $13,541 | |
| Funding Only Action | -$1 | |
| Funding Only Action | $65,379 | |
| Funding Only Action | -$12,475 | |
| Exercise an Option | $57,875 | |
| Supplemental Agreement for work within scope | -$15,000 | |
| Supplemental Agreement for work within scope | $118,350 | |
| Supplemental Agreement for work within scope | $0 | |
| Funding Only Action | $54,382 | |
| Other Administrative Action | $0 | |
| Original award | $50,000 |
Show all 12
About this award
This is a federal contract award to Leidos, Inc. by the U.S. Army Medical Command (MEDCOM) for the Bone Marrow Failure Research Program (BMFRP) under the Congressionally Directed Medical Research Programs (CDMRP). The contract, valued at $376,777.73, is a Delivery Order with a Cost Plus Fixed Fee pricing type and has an ultimate completion date of April 30, 2023. The contract does not have a set-aside designation. Leidos, Inc. is a large, global technology and engineering solutions provider that supports critical missions across national security, health, and other federal domains through its Leidos Services Operating Segment. This contract award demonstrates Leidos' capabilities in providing research and development, systems integration, and program management services to the U.S. Department of Defense.
Quick answers
Who was awarded contract W81XWH20F0134?
W81XWH20F0134 was awarded to Leidos, Inc. by Defense Health Agency (Department of Defense) on May 1, 2020.
How much is contract W81XWH20F0134 worth?
The government has obligated $328,176 on W81XWH20F0134. Its potential value, with all options, is $376,778.
Which agency awarded contract W81XWH20F0134?
Defense Health Agency (Department of Defense) awarded W81XWH20F0134, with funding from Medical Command (Department of the Army).
Is contract W81XWH20F0134 an order under another contract?
Yes. W81XWH20F0134 is a delivery order under W81XWH17D0025, an indefinite delivery contract.
Was contract W81XWH20F0134 competed?
The extent of competition for W81XWH20F0134 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award